投資評等
最後更新日期：2024/11/18
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2014/11/10 | Standpoint Research | Hold >> Buy | 28 |
| 2014/10/15 | Standpoint Research | Hold >> Buy | 21 |
| 2013/5/13 | Barclays | Equal Weight >> Overweight | $15 >> $20 |
| 2012/8/31 | Oppenheimer | Perform >> Outperform | 16 |
| 2011/7/28 | Miller Tabak | Hold >> Buy | $24 >> $22 |
| 2010/8/25 | Oppenheimer | Perform >> Outperform | 20 |
| 2010/5/10 | Brigantine | Hold >> Buy | 21 |
| 2010/4/19 | RBC Capital Mkts | Sector Perform >> Outperform | $24 >> $26 |
| 2010/3/18 | Thomas Weisel | Market Weight >> Overweight | |
| 2010/1/11 | Deutsche Bank | Hold >> Buy | $19 >> $24 |
| 2009/12/23 | ThinkEquity | Hold >> Buy | 35 |
| 2009/10/6 | UBS | Neutral >> Buy | |
| 2009/8/18 | Oppenheimer | Perform >> Outperform | 19 |
| 2009/3/23 | Citigroup | Hold Buy | 16 |
| 2006/6/9 | Needham & Co | Buy Strong Buy | 30 |
| 2005/2/7 | Needham Co | Buy->Strong Buy | 17 |
| 2005/1/26 | UBS | Neutral->Buy | |
| 2004/10/27 | Banc of America Sec | Neutral->Buy | |
| 2004/10/12 | AmTech Research | Hold->Buy | |
| 2004/6/18 | Morgan Stanley | Equal-weight->Overweight | 14 |
| 2004/4/26 | Schwab Soundview | Neutral->Outperform | $16 |
| 2004/4/23 | Buckingham Research | Accumulate->Strong Buy | 15 |
| 2004/1/5 | William Blair | Mkt Perform->Outperform | |
| 2003/12/18 | Goldman Sachs | In-Line->Outperform | |
| 2003/12/10 | JP Morgan | Neutral->Overweight | |
| 2003/7/23 | Deutsche Securities | Hold -> Buy | 10 |
| 2003/3/14 | UBS Warburg | Neutral -> Buy | 7 |
| 2003/2/10 | Bernstein | Mk -> Rerform -> Outperform | 7 |
| 2003/1/27 | UBS Warburg | Reduce -> Neutral | 4.25 |
| 2002/11/13 | Salomon Smth Brny | In-line -> Outperform | 3 |
| 2002/8/5 | Soundview Technology | Underperform -> Neutral | |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2014/11/4 | Standpoint Research | Buy >> Hold | |
| 2014/4/14 | Stifel | Buy >> Hold | |
| 2013/10/23 | Standpoint Research | Buy >> Hold | |
| 2013/9/3 | Oppenheimer | Outperform >> Perform | 18 |
| 2013/1/28 | Barclays | Overweight >> Equal Weight | |
| 2010/8/20 | Jefferies | Buy >> Hold | $24 >> $18.25 |
| 2010/2/23 | Oppenheimer | Outperform >> Perform | |
| 2009/9/8 | ThinkEquity | Buy >> Accumulate | $19 >> $17 |
| 2009/4/28 | Bernstein | Outperform Mkt Perform | |
| 2009/4/13 | Oppenheimer | Outperform Perform | |
| 2005/7/28 | Lazard Freres | Hold->Sell | 13 |
| 2004/12/2 | Needham Co | Strong Buy->Buy | |
| 2002/7/30 | Morgan Stanley | Equal-weight -> Underweight | |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2015/9/15 | Deutsche Bank | Buy | |
| 2013/9/23 | Gilford Securities | Buy | 20 |
| 2010/12/3 | Standpoint Research | Buy | 24 |
| 2010/10/11 | Brigantine | Buy | 21 |
| 2010/5/6 | Sterne Agee | Buy | 24 |
| 2010/3/16 | Brigantine | Hold | |
| 2009/12/11 | Jefferies & Co | Buy | |
| 2009/6/25 | Morgan Keegan | Outperform | |
| 2006/8/15 | Credit Suisse | Outperform | |
| 2005/10/5 | Goldman Sachs | In-Line | |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 2013/3/7 | Barclays | Equal Weight | 12 |
| 2012/8/21 | Stifel Nicolaus | Buy | 15 |
| 2003/1/27 | Morgan Stanley | Underweight | |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2015/10/28 | UBS | Neutral | $20 >> $19 |
| 2015/9/29 | Barclays | Overweight | $26 >> $25 |
| 2012/10/24 | National Securities | Buy | $16.50 >> $16 |
| 2011/6/22 | Barclays Capital | Overweight | $30 >> $28 |
| 2011/2/7 | Barclays Capital | Overweight | $25 >> $30 |
| 2011/1/26 | RBC Capital Mkts | Outperform | $23 >> $27 |
| 2011/1/25 | Miller Tabak | Hold | $20 >> $22 |
| 2011/1/12 | RBC Capital Mkts | Outperform | $22 >> $23 |
| 2010/11/1 | Brigantine | Buy | $21 >> $22 |
| 2010/9/14 | RBC Capital Mkts | Outperform | $26 >> $22 |